Nature Medicine
Latest articles published on Nature Medicine journal Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot
- 24 часа
- +5
- 7 дней
- +29
- 30 дней
- –
- Реакции
- 0
- Репосты
- –
- Комментарии
- –
Динамика подписчиков
Подписчиков у канала «Nature Medicine»: 7 163. Средний охват поста за сутки около 181, вовлечённость 2,5 %.
По дням, последние 30 дней
| Дата | Подписчики | Изменение | Посты | Ср. просмотры поста |
|---|---|---|---|---|
| 11 ноя | 7 163 | +5 | 2 | 79 |
| 10 ноя | 7 158 | +5 | 3 | 185 |
| 9 ноя | 7 153 | +7 | 2 | 220 |
| 8 ноя | 7 146 | +14 | 2 | 261 |
| 4 ноя | 7 132 | +156 | 2 | 341 |
| 4 окт | 6 976 | – | 0 | – |
Просмотры по возрасту поста
Средние просмотры в каждом возрасте, посты за последние 30 дней.
- 6 ч
- 98
- 24 ч
- 181
- 48 ч
- 217
- 3 дня
- 257
- 7 дней
- 268
Когда публикует
Время по UTC. 29 постов за 90 дней.
Последние посты
-
Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer https://www.nature.com/articles/s41591-026-04716-9 Nature Medicine, Published online: 11 November 2026; doi:10.1038/s41591-026-04716-9 (https://www.nature.com/articles/s41591-026-04716-9)This work developed and validated a computational pathology biomarker—the TROP2 normalized membrane ratio—that quantifies subcellular TROP2 localization and predicts improved progression-free and overall survival with datopotamab deruxtecan in patients with nonsquamous non-small-cell lung cancer lacking actionable genomic alterations.
79 просмотров 1 Реакции -
Lessons from recent investigator-initiated trials of gene-editing therapies in China https://www.nature.com/articles/s41591-026-04768-x Nature Medicine, Published online: 11 November 2026; doi:10.1038/s41591-026-04768-x (https://www.nature.com/articles/s41591-026-04768-x)Several deaths during trials of experimental cell and gene therapies in China appear to reveal gaps in governance and oversight. A new layer of independent external review is needed for clinical supervision of high-risk therapies.
80 просмотров -
Blood-based RNA biomarker for the early detection of ovarian cancer https://www.nature.com/articles/s41591-026-04732-9 Nature Medicine, Published online: 10 November 2026; doi:10.1038/s41591-026-04732-9 (https://www.nature.com/articles/s41591-026-04732-9)Tested in a cohort of 506 individuals, the RNA-based biomarker of microenvironment fitness Tu-stroma shows high performance in discriminating early-stage ovarian cancer from benign lesions, outperforming CA125.
185 просмотров 1 Реакции -
A novel candidate biomarker for detecting premalignant and early ovarian cancer https://www.nature.com/articles/s41591-026-04755-2 Nature Medicine, Published online: 10 November 2026; doi:10.1038/s41591-026-04755-2 (https://www.nature.com/articles/s41591-026-04755-2)New data suggest that the long noncoding RNA known as Tu-Stroma represents a promising new circulating biomarker for the detection of ovarian cancer at premalignant and early stages, for which sensitive screening methods currently are lacking.
194 просмотров -
Next-generation KRAS G12C inhibitor improves survival in lung cancer https://www.nature.com/articles/d41591-026-00057-9 Nature Medicine, Published online: 10 November 2026; doi:10.1038/d41591-026-00057-9 (https://www.nature.com/articles/d41591-026-00057-9)Phase 3 trial data show that the next-generation KRAS G12C inhibitor divarasib leads to longer progression-free survival than the first-generation inhibitors sotorasib and adagrasib in patients with non–small-cell lung cancer.
176 просмотров 1 Реакции -
An ulcerative colitis taxonomy defined by individual patient-reported response trajectories https://www.nature.com/articles/s41591-026-04741-8 Nature Medicine, Published online: 09 November 2026; doi:10.1038/s41591-026-04741-8 (https://www.nature.com/articles/s41591-026-04741-8)An analysis of patient-reported trajectories of response to vedolizumab in ulcerative colitis defines disease endotypes and identifies vascular inflammation as a potential resistance mechanism.
227 просмотров -
Deep learning-based gait analysis predicts multisystem health phenotypes https://www.nature.com/articles/s41591-026-04725-8 Nature Medicine, Published online: 09 November 2026; doi:10.1038/s41591-026-04725-8 (https://www.nature.com/articles/s41591-026-04725-8)We developed a gait foundation model from three-dimensional skeletal motion data of 3,328 deeply phenotyped adults, recorded using a depth camera during five motor tasks. Embeddings significantly predicted 1,887 of 3,210 phenotypic targets and provided predictive gains across all 18 body systems in men and 17 out of 18 in women, while also improving prediction of clinical diagnoses and medication use.
213 просмотров -
Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial https://www.nature.com/articles/s41591-026-04762-3 Nature Medicine, Published online: 08 November 2026; doi:10.1038/s41591-026-04762-3 (https://www.nature.com/articles/s41591-026-04762-3)As presented at the 2026 American Heart Association Scientific Sessions, in a placebo-controlled randomized clinical trial, semaglutide significantly improved pulmonary artery wedge pressure and other hemodynamic parameters during low-intensity exercise in individuals with heart failure with preserved ejection fraction and obesity.
275 просмотров -
Effects of semaglutide on cardiac structure and function in heart failure with preserved ejection fraction and obesity: a pre-specified cardiac magnetic resonance substudy of the CAMEO-SEMA trial https://www.nature.com/articles/s41591-026-04787-8 Nature Medicine, Published online: 08 November 2026; doi:10.1038/s41591-026-04787-8 (https://www.nature.com/articles/s41591-026-04787-8)As presented at the 2026 AHA Scientific Sessions, a cardiac magnetic resonance substudy of the CAMEO-SEMA trial showed that semaglutide significantly improved cardiac structure and function, including left atrial reservoir strain and left ventricular filling dynamics, in individuals with heart failure with preserve...
248 просмотров 1 Реакции -
A gait foundation model for prediction of multisystem health phenotypes from 3D skeletal motion https://www.nature.com/articles/s41591-026-04724-9 Nature Medicine, Published online: 06 November 2026; doi:10.1038/s41591-026-04724-9 (https://www.nature.com/articles/s41591-026-04724-9)A gait foundation model, developed using three-dimensional skeletal motion data from 3,328 adults, predicts a wide array of clinical characteristics and diagnoses, including cardiometabolic, mental health and frailty phenotypes.
319 просмотров
-
Insights into early-onset colorectal cancer from a single-nucleus RNA-seq atlas of colorectal cancer across the age continuum https://www.nature.com/articles/s41591-026-04721-y Nature Medicine, Published online: 29 October 2026; doi:10.1038/s41591-026-04721-y (https://www.nature.com/articles/s41591-026-04721-y)A high-resolution snRNA-seq atlas of 189 colorectal tumors from patients aged 20–90+ years uncovers age-associated features of colorectal cancer.
446 просмотров -
Climate change threatens malaria elimination in the Asia Pacific https://www.nature.com/articles/s41591-026-04722-x Nature Medicine, Published online: 30 October 2026; doi:10.1038/s41591-026-04722-x (https://www.nature.com/articles/s41591-026-04722-x)A multidisciplinary group of policymakers and researchers discusses the impacts of climate change on malaria in the Asia Pacific, identifies gaps in national adaptation strategies and outlines five priority actions for the region.
410 просмотров -
A clinical multimodal vision language foundation model with fine-grain explainability https://www.nature.com/articles/s41591-026-04655-5 Nature Medicine, Published online: 29 October 2026; doi:10.1038/s41591-026-04655-5 (https://www.nature.com/articles/s41591-026-04655-5)A multimodal vision language foundation model, EVLF-FM, integrates extensive clinical data and advanced training techniques, achieving superior diagnostic accuracy and explainability across diverse imaging modalities, enhancing clinical decision-making through robust reasoning and interpretability.
394 просмотров -
Perioperative ivonescimab with or without chemotherapy in resectable non-small cell lung cancer: a phase 2 trial https://www.nature.com/articles/s41591-026-04745-4 Nature Medicine, Published online: 04 November 2026; doi:10.1038/s41591-026-04745-4 (https://www.nature.com/articles/s41591-026-04745-4)In a nonrandomized phase 2 trial, patients with resectable non-small cell lung cancer received perioperative ivonescimab as monotherapy or with chemotherapy, leading to encouraging pathological response rates in both cohorts, and sustained circulating tumor DNA negativity throughout neoadjuvant therapy may be predictive of response.
371 просмотров -
Persistent and compartmentalized T cell immunity in ALS https://www.nature.com/articles/s41591-026-04728-5 Nature Medicine, Published online: 27 October 2026; doi:10.1038/s41591-026-04728-5 (https://www.nature.com/articles/s41591-026-04728-5)In ALS, persistent T cell responses relate to disease outcome differently in blood than in cerebrospinal fluid, with both intrathecal antigen presentation and cytomegalovirus-specific immunity linked to worse clinical outcomes.
361 просмотров -
Opposing microbiome-mediated axes link modifiable lifestyles to health and chronic diseases https://www.nature.com/articles/s41591-026-04744-5 Nature Medicine, Published online: 05 November 2026; doi:10.1038/s41591-026-04744-5 (https://www.nature.com/articles/s41591-026-04744-5)Fecal shotgun metagenomics from 6,803 adults in the Japanese 4D cohort and microbiome-based prediction scores validated across 13 independent and geographically diverse cohorts revealed two opposing microbiome-mediated axes linking lifestyle to health and 15 diseases.
355 просмотров 1 Реакции -
Editorial Expression of Concern: MicroRNA-133 controls cardiac hypertrophy https://www.nature.com/articles/s41591-026-04748-1 Nature Medicine, Published online: 28 October 2026; doi:10.1038/s41591-026-04748-1 (https://www.nature.com/articles/s41591-026-04748-1)Editorial Expression of Concern: MicroRNA-133 controls cardiac hypertrophy
345 просмотров -
5-year outcomes of chemotherapy de-escalation in HER2-positive early breast cancer and exploratory circulating tumor DNA analyses from the randomized phase 2 PHERGain trial https://www.nature.com/articles/s41591-026-04723-w Nature Medicine, Published online: 29 October 2026; doi:10.1038/s41591-026-04723-w (https://www.nature.com/articles/s41591-026-04723-w)A 5-year secondary analysis of the phase 2 PHERGain trial supports the clinical utility of a PET-guided adaptive strategy for treatment de-escalation in HER2-positive early breast cancer and provides circulating tumor DNA insights that could inform further treatment approaches.
326 просмотров -
Metabolic heterogeneity of obesity https://www.nature.com/articles/s41591-026-04718-7 Nature Medicine, Published online: 27 October 2026; doi:10.1038/s41591-026-04718-7 (https://www.nature.com/articles/s41591-026-04718-7)This Review examines the cellular, organ-level and whole-body differences between metabolically healthy and metabolically unhealthy obesity, as well as variations in response to weight loss—with the goal of improving strategies for preventing and treating obesity-related metabolic disorders.
326 просмотров -
Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials https://www.nature.com/articles/s41591-026-04739-2 Nature Medicine, Published online: 02 November 2026; doi:10.1038/s41591-026-04739-2 (https://www.nature.com/articles/s41591-026-04739-2)In the STOP-V1 and STOP-V2 trials, povorcitinib (an oral JAK1 inhibitor) was superior to placebo in improvement in F-VASI75 score in individuals with nonsegmental vitiligo.
323 просмотров
Вопросы о канале «Nature Medicine»
Сколько подписчиков у канала «Nature Medicine»?
У канала «Nature Medicine» (@nature_medicine) 7 163 подписчика на 12 ноября 2026 г.
Сколько человек видят пост в канале «Nature Medicine»?
Средний пост набирает около 180 просмотров за 24 часа, это примерно 3 % подписчиков (ERR).
О чём канал «Nature Medicine»?
Канал в категории «Здоровье», язык постов: английский. Описание канала: «Latest articles published on Nature Medicine journal Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot»
Какое место занимает канал «Nature Medicine»?
По числу подписчиков: №139 в категории «Здоровье», №2 598 среди каналов на языке «английский», №3 039 в мире.
Публикует ли канал «Nature Medicine» рекламу?
За последние 30 дней ни один из 29 постов не помечен как реклама (#ad, Sponsored, «Реклама»). Рекламу без пометки определить нельзя.
Когда публикует канал «Nature Medicine»?
Пик публикаций: вторник, около 12:00 по UTC. Выходит около 2 постов в день.
Статистика обновлена 5 минут назад.